222 related articles for article (PubMed ID: 38041068)
1. Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis.
Li R; Qiu J; Zhang Z; Qu C; Tang Z; Yu W; Tian Y; Tian H
Cancer Cell Int; 2023 Dec; 23(1):306. PubMed ID: 38041068
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Lymphocyte-Activation Gene 3 (LAG3) in Cancer: A Meta-Analysis.
Saleh RR; Peinado P; Fuentes-Antrás J; Pérez-Segura P; Pandiella A; Amir E; Ocaña A
Front Oncol; 2019; 9():1040. PubMed ID: 31681578
[No Abstract] [Full Text] [Related]
3. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of TIGIT in East Asian patients with solid cancers: A systematic review, meta-analysis and pancancer analysis.
Li S; Li L; Pan T; Li X; Tong Y; Jin Y
Front Immunol; 2022; 13():977016. PubMed ID: 36211383
[TBL] [Abstract][Full Text] [Related]
5. Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics data.
Shen C; Zhang S; Zhang Z; Yang S; Zhang Y; Lin Y; Fu C; Li Z; Wu Z; Wang Z; Li Z; Guo J; Li P; Hu H
Funct Integr Genomics; 2023 Jun; 23(3):211. PubMed ID: 37358720
[TBL] [Abstract][Full Text] [Related]
6. A combined analysis of multi-omics data reveals the prognostic values and immunotherapy response of LAG3 in human cancers.
Peng J; Du Z; Sun Y; Zhou Z
Eur J Med Res; 2023 Dec; 28(1):604. PubMed ID: 38115039
[TBL] [Abstract][Full Text] [Related]
7. CD274, LAG3, and IDO1 expressions in tumor-infiltrating immune cells as prognostic biomarker for patients with MSI-high colon cancer.
Lee SJ; Jun SY; Lee IH; Kang BW; Park SY; Kim HJ; Park JS; Choi GS; Yoon G; Kim JG
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1005-1014. PubMed ID: 29520442
[TBL] [Abstract][Full Text] [Related]
8.
Wu G; Chen M; Ren H; Sha X; He M; Ren K; Qi J; Lin F
Front Cell Dev Biol; 2022; 10():930933. PubMed ID: 35874816
[No Abstract] [Full Text] [Related]
9. Clinicopathological and prognostic value of epithelial cell adhesion molecule in solid tumours: a meta-analysis.
Ding P; Chen P; Ouyang J; Li Q; Li S
Front Oncol; 2023; 13():1242231. PubMed ID: 37664060
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of high IMP3 expression in solid tumors: a meta-analysis.
Chen L; Xie Y; Li X; Gu L; Gao Y; Tang L; Chen J; Zhang X
Onco Targets Ther; 2017; 10():2849-2863. PubMed ID: 28652767
[TBL] [Abstract][Full Text] [Related]
11. The prognostic role of tumor mutation burden on survival of breast cancer: a systematic review and meta-analysis.
Ke L; Li S; Cui H
BMC Cancer; 2022 Nov; 22(1):1185. PubMed ID: 36397030
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer.
Du J; Chen Y; Liu G; Zeng Q; Zhou N; Du D
Pathol Res Pract; 2023 Mar; 243():154374. PubMed ID: 36801507
[TBL] [Abstract][Full Text] [Related]
13. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
14. Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-Analysis.
Scirocchi F; Strigari L; Di Filippo A; Napoletano C; Pace A; Rahimi H; Botticelli A; Rughetti A; Nuti M; Zizzari IG
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430974
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Long Noncoding RNA CRNDE as a Novel Biomarker in Solid Cancers: An Updated Systematic Review and Meta-Analysis.
Zhou Y; Wang R; Xu T; Xie P; Zhang Y; Zhang A; Wang X; Yang C; Yang H; Zhu S
J Cancer; 2019; 10(11):2386-2396. PubMed ID: 31258743
[No Abstract] [Full Text] [Related]
16. Prognostic role of indoleamine 2,3-dioxygenase 1 expression in solid tumors: A systematic review and meta-analysis.
Zhang H; Li J; Zhou Q
Front Oncol; 2022; 12():954495. PubMed ID: 36212460
[TBL] [Abstract][Full Text] [Related]
17. Immune checkpoint inhibitors efficacy across solid cancers and the utility of PD-L1 as a biomarker of response: a systematic review and meta-analysis.
Fitzsimmons TS; Singh N; Walker TDJ; Newton C; Evans DGR; Crosbie EJ; Ryan NAJ
Front Med (Lausanne); 2023; 10():1192762. PubMed ID: 37250628
[TBL] [Abstract][Full Text] [Related]
18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
19. Tumor mutation load better predicts the prognosis of patients treated with immune checkpoint inhibitors in upper gastrointestinal cancers: A systematic review and meta-analysis.
Ma C; Teng Q; Shang L; Du F; Li L
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1959. PubMed ID: 38204354
[TBL] [Abstract][Full Text] [Related]
20. Association between Alpha B-crystallin expression and prognosis in patients with solid tumors: A protocol for systematic review and meta-analysis.
Yang M; Li Y; Tian F
Medicine (Baltimore); 2021 Feb; 100(7):e24831. PubMed ID: 33607849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]